ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$ARWR:NASDAQ · Arrowhead Pharmaceuticals Inc - US

Sector: health

Conviction from: NASDAQCitrini

52-week range: 37.0695.49

RNAi therapeutics drug developer

2 tracked filer(s) hold this · 0 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 68 — mean of 2 scored holder(s) · buyers (new/add) avg 61. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61Added +146%36,956$2,418,7700.0%
Steve Cohen / Point7275Trimmed -82%7,300$477,7850.0%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-05-14Trump, Donald J PresidentBUY$100,001 - $250,000PTR

Citrini Research coverage report library →

ReportDateStance
#135 — State of the Themes: The End of the Trade (As We Know It)2026-11-04WATCH
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.